Member Info for Richard08

You can compare different products whilst on there. I’m no medical professional but Dermapure appears to tick more boxes than other products!

There is competition, lots, but it doesn’t seem to be slowing TRX down. If you want a gander have a look:

https://www.woundsource.com/product-category/cellular-andor-tissue-based-products/non-viable-cells-tissue-based-human

This website is like the Amazon shop for surgeons. No prices unfortunately although I’m tempted to ask… DermaPure is on that page about half way down.

19th Sep according to dividendmax, usually fairly reliable site.

https://www.dividendmax.com/united-kingdom/london-stock-exchange/mining/atalaya-mining-plc/dividends

And the positive news flows on! Another successful project deploying Invinity’s tech in a novel way to smooth out renewable energy’s variability. Keep up the good work!

Certainly to have as much as possible in terms of manufacturing, vanadium supply etc coming from the US makes sense in light of the Inflation reduction act which seems to be a climate change ad stimulus package rolled into one. A climate change bill has been on the cards for a while now and it’s possible, indeed quite likely IMO, that IES have been aiming in this direction for some time and it’s mere serendipity that the recent focus on the US and this bill arrived at the same time. Unless Larry has fingers in pies we don’t know about?? Either way, there’s nothing like a macro trend, massive govt funding and a Californian CEO to help this along. California is one of the greenest regions on Earth and also one of the world’s largest economies. A 24% bounce today is heading in the right direction.

More irons in the fire for IES. And this will appeal far more state side than it does here which is all to the good given the new listing. The share price does not currently reflect the work the company is doing and the connections they are building. But it will in time.

Thanks guys. Interesting to see he owns a chunk of Totally as that was one on my watchlist.

I’ve been having a nosey to see if I can find other companies that Imthallo hold but without success; anybody else know of any? Incidentally Richard Snellor would have been at Baillie G when they chose TRX for their Edinburgh WorldWide Fund. He managed a different fund, very successfully, but it’s possible he’s been watching TRX for along time. The fact that he has invested now gives me huge confidence.

Absolutely HighlyGeared, huge amounts of due diligence will have been undertaken by them, maybe under a NDA? We may find out more at the interims. Either way, massive vote of confidence and will encourage others to buy and discourage sellers.

Big vote of confidence that, have a look at their website. This is exactly the kind of positive attention that will get TRX moving. I sense a bit of FOMO kicking in today, never thought I’d see it! I’m going to jinx it now by saying last time perhaps that we will see sub 0.5p? Believe me when I say that I’m holding every lucky charm whilst typing that!!!

Absolutely, and the sp agrees with us this morning!

RNS says it all really, there’s nothing like a legislative push and vast amounts of govt funding to kick start something. This company has more than enough American connections to appeal to the US investor, excellent timing for the OTC listing!

Almost 10% of the share float changed hands today. And in a positive direction for the sp too. Will be interesting to see if the momentum spills over into tomorrow too. There are only so many days left before the September results come in. Buy now whilst stocks last! Several attractive points to TRX right now:
1) Operates in medical 'device' market which is largely inflation proof. Obviously also in healthcare sector which is inflation resistant in itself so a double plus.
2) Hopefully (don't want to jinx it!) TRX is about to break even which will obviously help the companies image.
3) For the chartists out there, brace yourself for this insightful analysis, all the lines are pointing upwards so therefore I'm happy! Seriously though, it's above the Ichimoku cloud having also passed through the 50 day moving average a few weeks ago. The 200 day is at about 0.55p so not far off. Passing through that would be a really bullish signal.
4) Everything is priced in US dollars, which lets face it, is a somewhat stronger currency than the pound at the moment.
Fingers crossed and good luck all!

Nice little find platoh, at least they have something good to boast about!

Minor adjustment by Harwood there, hardly worth noticing.

But, Happy Yorkshire Day to all the fellow Yorkshire men out there. TRX is also from Yorkshire as you probably know although only loosely connected these days…

And don’t worry if you’re not from Yorkshire: no-one is perfect ;)

To be honest Agricore, I was lazily reading it off the ratios menu on Trading212 so I have no loyalty to my ‘calculation’! Certainly looking at your suggestions we can agree this is undervalued to a large extent. Given the pipeline and the approximate conversion of this to sales & revenue there is definitely a market there that is being severely discounted by the market.

Whist IES does not have a PE ratio at the moment, the PS has dropped to 14 (it was up at a silly level in the thousands before the latest trading update) which is still relatively high but the price to book value has dropped to 0.89 which means IES is technically undervalued. Now, there are obvious reasons for this, but for those who have completed their due diligence (and let’s face it, have a lot of faith in Larry et al) now would be a ‘safe’ moment to buy more. Ben Graham used to swear by the PB ratio, although Buffet has more recently questioned it’s viability as a measure. However, stocks with their PB below one are still regarded as undervalued. GLA

I had the same problem with 212 kebark, but I found that trades submitted before 8:30 seemed to have a greater chance of going through more or less straight away.

https://www.proactiveinvestors.co.uk/companies/news/988077/tissue-regenix-four-pronged-strategy-helping-deliver-on-growth-aspirations-988077.html

Nothing new here for the well informed holder, but good to see a positive write up from a neutral source.

This appears to still be a largely undiscovered gem that keeps delivering. It will be interesting to see the market reaction today.